Lineage Cell Therapeutics, Inc. Quarterly Common Stock, Shares, Issued from Q4 2010 to Q3 2024

Taxonomy & unit
us-gaap: shares
Description
Total number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.
Summary
Lineage Cell Therapeutics, Inc. quarterly Common Stock, Shares, Issued history and growth rate from Q4 2010 to Q3 2024.
  • Lineage Cell Therapeutics, Inc. Common Stock, Shares, Issued for the quarter ending September 30, 2024 was 189M shares, a 7.92% increase year-over-year.
Common Stock, Shares, Issued, Quarterly (shares)
Common Stock, Shares, Issued, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 189M +13.9M +7.92% Sep 30, 2024 10-Q 2024-11-14
Q2 2024 189M +14.4M +8.25% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 189M +18.6M +10.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 175M +4.89M +2.88% Dec 31, 2023 10-Q 2024-11-14
Q3 2023 175M +5.1M +3% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 174M +4.69M +2.76% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 170M +446K +0.26% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 170M +616K +0.36% Dec 31, 2022 10-K 2024-03-07
Q3 2022 170M +1.42M +0.84% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 170M +2.71M +1.62% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 170M +7.66M +4.73% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 169M +16.4M +10.7% Dec 31, 2021 10-K 2023-03-09
Q3 2021 168M +18.5M +12.3% Sep 30, 2021 10-Q 2021-11-10
Q2 2021 167M +17.2M +11.5% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 162M +12.2M +8.18% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 153M +3.29M +2.2% Dec 31, 2020 10-K 2022-03-10
Q3 2020 150M +201K +0.13% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 150M +188K +0.13% Jun 30, 2020 10-Q 2020-08-06
Q1 2020 150M +430K +0.29% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 150M +22.7M +17.8% Dec 31, 2019 10-K 2021-03-11
Q3 2019 150M +22.9M +18.1% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 150M +22.8M +17.9% Jun 30, 2019 10-Q 2019-08-08
Q1 2019 149M +22.5M +17.8% Mar 31, 2019 10-Q 2019-05-09
Q4 2018 127M +270K +0.21% Dec 31, 2018 10-K 2020-03-12
Q3 2018 127M +11.1M +9.57% Sep 30, 2018 10-Q 2018-11-08
Q2 2018 127M +16M +14.4% Jun 30, 2018 10-Q 2018-08-02
Q1 2018 127M +16M +14.4% Mar 31, 2018 10-Q 2018-05-10
Q4 2017 127M +23.5M +22.7% Dec 31, 2017 10-K 2019-03-14
Q3 2017 116M +12.4M +12% Sep 30, 2017 10-Q 2017-11-09
Q2 2017 111M +8.59M +8.4% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 111M +16M +16.8% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 103M +8.5M +8.96% Dec 31, 2016 10-K 2018-03-15
Q3 2016 103M +16.6M +19.2% Sep 30, 2016 10-Q 2016-11-04
Q2 2016 102M +19M +22.8% Jun 30, 2016 10-Q 2016-08-09
Q1 2016 94.9M +11.7M +14% Mar 31, 2016 10-Q 2016-05-10
Q4 2015 94.9M +11.8M +14.2% Dec 31, 2015 10-K 2017-03-16
Q3 2015 86.8M +13.1M +17.7% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 83.3M +11M +15.2% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 83.2M +13.6M +19.5% Mar 31, 2015 10-Q 2015-05-08
Q4 2014 83.1M +15.7M +23.3% Dec 31, 2014 10-K 2016-03-15
Q3 2014 73.7M +15.8M +27.2% Sep 30, 2014 10-Q 2014-11-07
Q2 2014 72.3M +14.3M +24.7% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 69.6M +14.7M +26.8% Mar 31, 2014 10-Q 2014-05-12
Q4 2013 67.4M +16.2M +31.7% Dec 31, 2013 10-K 2015-03-11
Q3 2013 57.9M +7.07M +13.9% Sep 30, 2013 10-Q 2013-11-12
Q2 2013 57.9M +7.14M +14.1% Jun 30, 2013 10-Q 2013-08-09
Q1 2013 54.9M +4.59M +9.12% Mar 31, 2013 10-Q 2013-05-10
Q4 2012 51.2M +861K +1.71% Dec 31, 2012 10-K 2014-03-17
Q3 2012 50.9M +631K +1.26% Sep 30, 2012 10-Q 2012-11-09
Q2 2012 50.8M +1.92M +3.93% Jun 30, 2012 10-Q 2012-08-09
Q1 2012 50.3M Mar 31, 2012 10-Q 2012-05-10
Q4 2011 50.3M +2.54M +5.33% Dec 31, 2011 10-K 2013-03-18
Q3 2011 50.2M Sep 30, 2011 10-Q 2011-11-08
Q2 2011 48.9M Jun 30, 2011 10-Q 2011-08-09
Q4 2010 47.8M Dec 31, 2010 10-K 2012-03-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.